entertainment -WSS

entertainment

author：fashion 2025-08-29 01:53:49 - browse：7

Parts of a DNA spotlighted -- Coverage from STAT — Adobe

Ring Therapeutics, a gene therapy startup launched by Flagship Pioneering, has laid off just under 20% of its staff, or 19 employees, Flagship confirmed to STAT.

The move comes as Sonata Therapeutics, another Flagship startup, has let go of a third of its staff, part of a broader hunkering down by platform companies. As funding for private biotechs remains scarce, startups hoping to develop new technologies — always an expensive, setback-ridden process — have had to make tough choices on staffing and priorities.

Ring had been particularly ambitious. The company is trying to engineer a new class of viruses as vehicles for delivering genes into patients’ cells. These viruses, tiny bugs called anelloviruses, had the potential to be safer and more versatile than the viruses currently used for gene therapy, called AAVs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

WSS

Novo pauses ads for weight loss drug Wegovy amid demand

Inside the rise of 'mukbang' eating videos

Popular nasal decongestant doesn't actually relieve congestion

How medical schools plan to diversify without affirmative action

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

Acelyrin, a rare IPO success, stumbles in its first big test

explore

entertainment

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

Walmart eyes Medicare Advantage provider ChenMed

Guidelines to prevent youth baseball injuries need more muscle

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Moonlake's readout produced a cash windfall. Risks remain

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Drug repurposing or repositioning? The language matters

How medical schools plan to diversify without affirmative action

Trump demands the U.S. pay no more for drugs than other countries … again

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

focus

Mom launches Girl Scout troop for LGBTQ youth in Texas

FDA approves first new drug developed for postpartum depression

Timeline: Key moments in fight for gay rights

IRA could hurt research into orphan drugs for rare diseases

What to make of Biden’s latest efforts on cancer research

A common UTI test for kids haunts adults as a traumatic 'nightmare'

hotspot

focus

focus

focus